The 2024 Outlook For Global Pharma

The 2024 Outlook For Global Pharma: A Look Ahead - Forbes

Our recently released Numerof & Associates 2024 Global Pharma Outlook highlights some of the key areas where pharma companies will continue to face great ...

2024 Global Life Sciences Sector Outlook - Deloitte

In our 2024 Global Life Sciences Sector Outlook report, we emphasize on these key trends such as increasing pricing pressures, geopolitical environment, ...

Pharma trends 2024: Shaping the future landscape | ZS

The forces shaping pharma's 2024 outlook · Health system reforms. Drug manufacturers face stricter access and pricing environments across key ...

Next in pharma 2024: Reinventing for returns - PwC

Next in pharma 2024: Reinventing for returns · Accelerate growth through AI and analytics · Pharma companies should increase speed across the value chain through ...

The Global Use of Medicines 2024: Outlook to 2028 - IQVIA

The updated outlook for the U.S. market, using estimated net prices, is being raised by 3 percentage points to 2-5% CAGR through 2028, ...

The Numerof 2024 Global Pharma Outlook

As our Numerof 2024 Global Pharma Outlook infographic illustrates, this year's story for pharmaceutical manufacturers will be about responding to growing ...

Global Pharmaceutical Industry Outlook 2024 - Frost & Sullivan

Global Pharmaceutical Industry Outlook, 2024: Growing Competitive Intensity is Driving Pharma Digitization, Building Unique Growth Opportunities.

Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue ...

Through 2027, S&P Global Ratings expects healthy, organic revenue growth of at least low- to mid-single-digit percent for most of the large, ...

Pharmaceuticals Global Industry Guide 2024: A $1.38

The global pharmaceuticals market registered revenue of $1.38 trillion in 2023, representing a compound annual growth rate (CAGR) of 3.1% ...

Global pharmaceutical and biotech 2024 outlook | Statista

This report was published by EP Vantage and EvaluatePharma at year-end 2023. It provides an outlook of the pharmaceutical and biotechnology market in 2024, ...

World Preview 2024 – Pharma's Growth Boost - eBook | Evaluate

Obesity drugs will dominate 2030 forecasts, with new technologies and strong pharma acquisitions boosting biotech growth.

Global Pharma Industry Outlook: The Ups and Downs & Projections ...

Overall, the global bio/pharmaceutical market was valued at $1.3 trillion in 2023, with the US representing 52% of the global market on a value ...

Global Pharma & Biotech Outlook 2024 - Fitch Ratings

Fitch Ratings' neutral outlook for the global pharmaceutical (pharma) and biotech industry reflects Fitch's assumption of good growth in 2024.

Global M&A trends in health industries: 2024 mid-year outlook | PwC

Dealmakers in pharmaceuticals and life sciences and in healthcare services are eager to get deals done in 2024 as they grow more comfortable ...

Global Trends in R&D 2024: Activity, productivity, and enablers - IQVIA

Global Trends in R&D 2024 is an annual trend report from the IQVIA Institute that assesses the trends in new drug launches and the overall ...

Midyear Global Outlook for Life Science | Deloitte US

We are halfway through 2024, and the seeds of disruption appear to be broadly spread across the pharma, biotech, and medtech industries shaping ...

Industry Trends Pharmaceuticals September 2024

Looking ahead global pharmaceuticals output growth will remain robust, forecast to increase by 3% in 2024, 4% in 2025 and 3.6% in 2026.

2024 Healthcare and Life Sciences Investment Outlook

Biopharma services: Still adjusting to a post-COVID-19 world, many CDMOs and other pharma services companies face uneven demand and heightened competition; ...

2024 Outlook and Expectations For Global Pharma, Biopharma and ...

Join BI's global healthcare team as they discuss issues, expectations and key events anticipated in 2024 for Pharma, Biopharma and Biotech.

Top 12 Pharmaceutical Industry Trends in 2024 - Global Pharma Tek

The popularity of biologics is expected to grow in the year 2024. This is because they offer more targeted and effective treatments for various ...